lenalidomida teva 10 mg
teva operations poland sp. z.o.o - polonia - lenalidomidum - caps. - 10mg - imunosupresoare alte imunosupresoare
lenalidomida teva 15 mg
teva operations poland sp. z.o.o - polonia - lenalidomidum - caps. - 15mg - imunosupresoare alte imunosupresoare
lenalidomida teva 20 mg
teva operations poland sp. z.o.o - polonia - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare
lamisil comprimate 250 mg
novartis pharma ag - terbinafinum - comprimate - 250 mg
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - agenți antineoplazici - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
amoxicilina capsule 250 mg
balkan pharmaceuticals srl, sc - amoxicillinum - capsule - 250 mg
amoxicilina capsule 500 mg
balkan pharmaceuticals srl, sc - kalii - capsule - 500 mg
nimenrix
pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningită, meningococică - vaccinuri - nimenrix este indicat pentru imunizarea activă a persoanelor de la vârsta de 6 săptămâni împotriva bolilor meningococice invazive cauzate de grupul neisseria meningitidis a, c, w-135 și y.
clometryl ovule
farmaprim srl - combinaţie - ovule
clometryl forte ovule
farmaprim srl - combinaţie - ovule